[{"AccountsPayableCurrent_0_Q1_USD":73500000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q1_shares":200000.0,"TreasuryStockValue_0_Q1_USD":8900000.0,"IncreaseDecreaseInAccountsPayableTrade_1_Q1_USD":-8200000.0,"EarningsPerShareDiluted_1_Q1_USD":0.08,"ProceedsFromStockOptionsExercised_1_Q1_USD":0.0,"OtherInventorySupplies_0_Q1_USD":4000000.0,"InvestmentIncomeInterest_1_Q1_USD":700000.0,"IncomeTaxesReceivable_0_Q1_USD":28900000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":10600000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-7400000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":11000000.0,"TaxesPayableCurrent_0_Q1_USD":3300000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-14900000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-11200000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":38300000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-14500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":47800000.0,"OtherAssetsNoncurrent_0_Q1_USD":10900000.0,"LongTermDebt_0_Q1_USD":248200000.0,"InventoryLIFOReserve_0_Q1_USD":6900000.0,"Goodwill_0_Q1_USD":799800000.0,"GainLossOnDispositionOfAssets1_1_Q1_USD":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":17000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":15900000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":15300000.0,"AccruedSalariesCurrent_0_Q1_USD":22800000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q1_USD":15100000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":187700000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":179300000.0,"OtherOperatingActivitiesCashFlowStatement_1_Q1_USD":-6400000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_1_Q1_USD":-100000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1_Q1_USD":-200000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_1_Q1_USD":0.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_1_Q1_USD":-100000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_1_Q1_USD":-100000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q1_USD":-100000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-15000000.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-200000.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent_1_Q1_USD":-300000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":59900000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":58800000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":14300000.0,"NumberOfReportableSegments_1_Q1_segment":1.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"IncomeLossAttributableToParent_1_Q1_USD":-3000000.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":-1100000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":13500000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-6600000.0,"DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0_Q1_USD":1600000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-17600000.0,"AccruedIncomeTaxesNoncurrent_0_Q1_USD":400000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":10800000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2500000.0,"AccountsReceivableGrossCurrent_0_Q1_USD":162800000.0,"PaymentsToAcquireProductiveAssets_1_Q1_USD":5200000.0,"OtherSundryLiabilitiesNoncurrent_0_Q1_USD":5300000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q1_USD":102500000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":78300000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":23700000.0,"OtherOperatingIncomeExpenseNet_1_Q1_USD":-1000000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_1_Q1_USD":-15000000.0,"NetIncomeLoss_1_Q1_USD":3700000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-5800000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-5200000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":0.0,"LiabilitiesCurrent_0_Q1_USD":189400000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":1763700000.0,"Liabilities_0_Q1_USD":507200000.0,"InventoryNet_0_Q1_USD":153100000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":2000000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-17000000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-6700000.0,"GrossProfit_1_Q1_USD":102100000.0,"Depreciation_1_Q1_USD":5800000.0,"CommonStockValue_0_Q1_USD":500000.0,"CommonStockSharesOutstanding_0_Q1_shares":47755911.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":187700000.0,"AssetsCurrent_0_Q1_USD":524100000.0,"Assets_0_Q1_USD":1763700000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":1200000.0,"AdditionalPaidInCapital_0_Q1_USD":1596400000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-46900000.0,"AccountsReceivableNetCurrent_0_Q1_USD":159600000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":178700000.0,"EarningsPerShareBasic_1_Q1_USD":0.08,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-284600000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":101600000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":179300000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":433300000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":280800000.0,"InventoryWorkInProcess_0_Q1_USD":29200000.0,"InventoryRawMaterials_0_Q1_USD":53300000.0,"InventoryGross_0_Q1_USD":160000000.0,"InventoryFinishedGoods_0_Q1_USD":73500000.0,"IncreaseDecreaseInInventories_1_Q1_USD":8500000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":4800000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":102100000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":48000000.0,"ShareBasedCompensation_1_Q1_USD":2500000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":91100000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":9400000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":20000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":0.0,"OperatingIncomeLoss_1_Q1_USD":600000.0,"InterestExpense_1_Q1_USD":4300000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":254000000.0,"CommonStockSharesAuthorized_0_Q1_shares":300000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"CommitmentsAndContingencies_0_Q1_USD":null,"StockholdersEquity_0_Q1_USD":1256500000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":180400000.0,"Ticker":"AVNS","CIK":"1606498","name":"AVANOS MEDICAL, INC.","OfficialName":"Avanos Medical Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1515595188.0","Country":"United States","Sector":"Health Care","Industry":"Industrial Specialties","Market":"NYSE","SP500":"nan","filed":"20200506"}]